Compare CXDO & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CXDO | NAUT |
|---|---|---|
| Founded | 1995 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Laboratory Analytical Instruments |
| Sector | Telecommunications | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 223.1M | 245.0M |
| IPO Year | 1998 | N/A |
| Metric | CXDO | NAUT |
|---|---|---|
| Price | $6.07 | $2.15 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $9.13 | N/A |
| AVG Volume (30 Days) | 169.4K | ★ 179.8K |
| Earning Date | 03-03-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 201.70 | N/A |
| EPS | ★ 0.14 | N/A |
| Revenue | ★ $66,346,000.00 | N/A |
| Revenue This Year | $14.40 | N/A |
| Revenue Next Year | $11.52 | N/A |
| P/E Ratio | $43.17 | ★ N/A |
| Revenue Growth | ★ 12.91 | N/A |
| 52 Week Low | $3.75 | $0.62 |
| 52 Week High | $7.80 | $2.54 |
| Indicator | CXDO | NAUT |
|---|---|---|
| Relative Strength Index (RSI) | 37.27 | 53.90 |
| Support Level | $6.12 | $1.97 |
| Resistance Level | $6.60 | $2.20 |
| Average True Range (ATR) | 0.42 | 0.17 |
| MACD | -0.10 | 0.01 |
| Stochastic Oscillator | 3.40 | 67.96 |
Crexendo Inc is a provider of cloud communications, UCaaS, call centers, collaboration services, and other cloud business services. The company operates through two segments: Cloud telecommunications and Software Solutions. Its cloud telecommunications segment offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over any high-speed Internet connection. The Software Solutions segment is involved in revenue generation from software licenses, software maintenance support, and professional services. It generates subscription and maintenance support revenue from customer support and other supportive services. The company offers warranties on its products. It derives a majority of its revenue from the Cloud telecommunications segment.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.